Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281619727> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4281619727 endingPage "1047" @default.
- W4281619727 startingPage "1039" @default.
- W4281619727 abstract "Omni® (B Braun, Melsungen, Germany) is able to run continuous renal replacement therapy (CRRT) in continuous veno-venous hemofiltration (CVVH), hemodialysis (CVVHD), and hemodiafiltration (CVVHDF) modes. However, to date, there is no validated protocol to guide the use of Omni® in CVVHDF mode with regional citrate anticoagulation (RCA).We designed a protocol for CVVHDF-RCA tailored for Omni®. This protocol was tested in patients included in an observational study conducted in our center between January and March 2021. For all study patients, we collected baseline characteristics, laboratory results, CRRT circuit lifespan as well as plasma and effluent samples at 12, 24, 48, and 72 h of CRRT circuit initiation. At each study time point, we computed urea, creatinine, and β2-microglobulin clearance as well as effluent/blood ratios. Data from circuits in CVVHDF-RCA mode are compared with those in standard therapy (CVVHD-RCA) with the same device.We analyzed ten circuits (5 patients) in CVVHDF-RCA mode and 32 (13 patients) in CVVHD-RCA mode. No adverse events related to the therapy were observed. In CVVHDF-RCA mode, median circuit running time was 68 (IQR 8.1) hours versus 46 (IQR 9.0) in CVVHD mode, p = 0.053. Therapy adaptations (dialysate rate and/or blood flow) were required in one (10%) circuit (15.6% in CVVHD mode, p = 0.56). Compared to CVVHD, CVVHDF was able to achieve similar clearance and effluent/blood ratio for urea, creatinine, and β2-microglobulin across the entire duration of circuit lifetime.The proposed protocol for CVVHDF-RCA for Omni® was associated with similar circuit lifetime, number of required adaptations and clearances to standard CVVHD-RCA. It appears to be safe and feasible." @default.
- W4281619727 created "2022-06-13" @default.
- W4281619727 creator A5002056568 @default.
- W4281619727 creator A5053234000 @default.
- W4281619727 creator A5061626282 @default.
- W4281619727 creator A5073851208 @default.
- W4281619727 creator A5082190633 @default.
- W4281619727 creator A5084957270 @default.
- W4281619727 date "2022-01-01" @default.
- W4281619727 modified "2023-10-05" @default.
- W4281619727 title "Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®" @default.
- W4281619727 cites W1798010974 @default.
- W4281619727 cites W1970024336 @default.
- W4281619727 cites W1974164278 @default.
- W4281619727 cites W2041870951 @default.
- W4281619727 cites W2045389133 @default.
- W4281619727 cites W2075115843 @default.
- W4281619727 cites W2076330369 @default.
- W4281619727 cites W2085841350 @default.
- W4281619727 cites W2091259644 @default.
- W4281619727 cites W2109172549 @default.
- W4281619727 cites W2115045883 @default.
- W4281619727 cites W2115146242 @default.
- W4281619727 cites W2134661992 @default.
- W4281619727 cites W2144226365 @default.
- W4281619727 cites W2155393409 @default.
- W4281619727 cites W2171478303 @default.
- W4281619727 cites W2556404592 @default.
- W4281619727 cites W2599076725 @default.
- W4281619727 cites W2619666919 @default.
- W4281619727 cites W2768801834 @default.
- W4281619727 cites W3094020901 @default.
- W4281619727 cites W4292229870 @default.
- W4281619727 cites W4292528167 @default.
- W4281619727 doi "https://doi.org/10.1159/000524329" @default.
- W4281619727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35636389" @default.
- W4281619727 hasPublicationYear "2022" @default.
- W4281619727 type Work @default.
- W4281619727 citedByCount "0" @default.
- W4281619727 crossrefType "journal-article" @default.
- W4281619727 hasAuthorship W4281619727A5002056568 @default.
- W4281619727 hasAuthorship W4281619727A5053234000 @default.
- W4281619727 hasAuthorship W4281619727A5061626282 @default.
- W4281619727 hasAuthorship W4281619727A5073851208 @default.
- W4281619727 hasAuthorship W4281619727A5082190633 @default.
- W4281619727 hasAuthorship W4281619727A5084957270 @default.
- W4281619727 hasBestOaLocation W42816197271 @default.
- W4281619727 hasConcept C126322002 @default.
- W4281619727 hasConcept C141071460 @default.
- W4281619727 hasConcept C2778063415 @default.
- W4281619727 hasConcept C2778865887 @default.
- W4281619727 hasConcept C2779541074 @default.
- W4281619727 hasConcept C2780306776 @default.
- W4281619727 hasConcept C42219234 @default.
- W4281619727 hasConcept C71924100 @default.
- W4281619727 hasConceptScore W4281619727C126322002 @default.
- W4281619727 hasConceptScore W4281619727C141071460 @default.
- W4281619727 hasConceptScore W4281619727C2778063415 @default.
- W4281619727 hasConceptScore W4281619727C2778865887 @default.
- W4281619727 hasConceptScore W4281619727C2779541074 @default.
- W4281619727 hasConceptScore W4281619727C2780306776 @default.
- W4281619727 hasConceptScore W4281619727C42219234 @default.
- W4281619727 hasConceptScore W4281619727C71924100 @default.
- W4281619727 hasIssue "12" @default.
- W4281619727 hasLocation W42816197271 @default.
- W4281619727 hasLocation W42816197272 @default.
- W4281619727 hasLocation W42816197273 @default.
- W4281619727 hasOpenAccess W4281619727 @default.
- W4281619727 hasPrimaryLocation W42816197271 @default.
- W4281619727 hasRelatedWork W1515221463 @default.
- W4281619727 hasRelatedWork W2018068161 @default.
- W4281619727 hasRelatedWork W2078896287 @default.
- W4281619727 hasRelatedWork W2085646992 @default.
- W4281619727 hasRelatedWork W2115045883 @default.
- W4281619727 hasRelatedWork W2362302983 @default.
- W4281619727 hasRelatedWork W2399872744 @default.
- W4281619727 hasRelatedWork W2473417475 @default.
- W4281619727 hasRelatedWork W2954268467 @default.
- W4281619727 hasRelatedWork W2528028881 @default.
- W4281619727 hasVolume "51" @default.
- W4281619727 isParatext "false" @default.
- W4281619727 isRetracted "false" @default.
- W4281619727 workType "article" @default.